Purpose Patients' physiological functions and health-related quality of life (QOL) are useful
for planning physical therapy after allogeneic hematopoietic stem-cell transplantation (allo …

Objective The aim of this study was to examine gender differences in quality of life (QOL),
physical function and psychological status before and in the early phase after allogeneic …

Myelodysplastic syndromes (MDS) encompass a variety of myeloid neoplasms
characterized by ineffective hematopoiesis. The interaction of abnormal clonal …

Relapse after allogeneic hematopoietic stem cell transplantation (HSCT) is a major concern
in myelodysplastic syndromes (MDS), but the role of Wilms tumor gene 1 (WT1) as a …

Allogeneic hematopoietic stem cell transplantation (alloSCT) is currently the only curative
treatment modality for myelodysplastic syndromes (MDS). The treatment paradigm for MDS …

This study describes a retrospective analysis on the transplant outcome of 56 consecutive
patients with myelodysplastic syndrome (MDS) according to their response to …

Allogeneic hematopoietic cell transplantation (HCT) can be curative for both myelodysplastic
syndromes (MDS) and lymphoid malignancies. Little is known about the efficacy of …

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the only curative
treatment in both MDS and CMML. In MDS, there is an increasing prevalence of high-risk …

Allogeneic stem cell transplantation is a potentially curative treatment for myelodysplastic
syndromes. Transplants are clearly indicated in patients with intermediate-2 and high risk …

Background A number of alternative donor options exist for patients who fail to find domestic
HLA-matched donors for allogeneic hematopoietic stem cell transplantation (allo-HSCT). We …